The patient populations your research can't afford to miss
Oatmeal Health gives pharma, biotech, medtech, and diagnostics companies direct access to diverse, underserved patient populations through our nationwide network of Community Health Centers. From clinical trials to real-world evidence studies, we bring the patients your programs need.
The infrastructure that takes years to build, ready now
Building community site relationships, earning credentialing, and deploying the AI to find and reach patients typically takes sponsors years and millions of dollars. We have already done it. You get access on day one.
We have established partnerships with Federally Qualified Health Centers across the country, serving 34M+ patients. We operate with credentialing at the FQHCs.
Our AI parses EHR data across structured and unstructured fields to find every patient who meets your protocol criteria, scored by risk, reachability, and eligibility confidence. No manual chart review required.
Our patient base reflects the communities that clinical research has historically excluded. We have the demographic data, the outreach infrastructure, and the community trust to enroll and retain patients who are typically hardest to reach.
Once eligible patients are identified, our AI agents run outreach at scale across SMS, voice, and email, in multiple languages. Interested patients are scheduled directly. We handle reminders, rescheduling, and completion tracking.
One partner network. Every use case your program needs.
Whether you are enrolling a pivotal trial, building a real-world evidence dataset, meeting FDA diversity requirements, or validating a diagnostic, Oatmeal Health connects you to the community patient populations that make the difference.
Most trials underenroll patients from low-income and minority communities, not because they don't qualify, but because no one has reached them. Our FQHC network changes that.
Post-approval studies and payer submissions increasingly require evidence from the populations who actually use your therapy. Our network generates longitudinal outcomes data from community health settings.
The FDA's Diversity Action Plan requirements are not going away. More than 60% of our patients come from racial and ethnic minority communities, with verified demographic documentation for regulatory submissions.
Devices validated only in academic medical centers often perform poorly in community health settings. We give diagnostics and medtech companies access to real-world cohorts where performance gaps matter most.
From protocol to enrolled patient in weeks, not years
We handle the infrastructure. You focus on the science. Here is how a typical partnership engagement unfolds from first conversation to active enrollment.
Let's talk about your program
Tell us about your trial, study, or validation program and we will tell you exactly what enrollment from our network looks like. No commitment required to get a feasibility assessment.
We respond within one business day.